Research

Does nicotine really boost IQ by 10 points? A breakdown of the evidence behind bold claims, cognitive effects, and what the research actually shows.

Researchers discover a rare gene variant that slashes smoking by up to 78%. New study reveals how CHRNB3 mutations could inspire life-changing drug therapies.

A new Frontiers mini-review examines nicotine pouches, oral cancer risk and harm reduction potential in South and Southeast Asia.

A new study in Addiction shows smokers who continue vaping after quitting are significantly less likely to relapse than those who stop using e-cigarettes.

New UK study shows nicotine pouch use rose tenfold between 2020–2025. Who’s using them, what it means for smoking rates, and regulation.

Explore the reliability of youth nicotine pouch use statistics and the impact of self-reporting biases. Could the figures be inflated, affecting policy decisions?

Exploring the potential of nicotine as a treatment for mild cognitive impairment and Alzheimer's disease, backed by scientific research.

Duke researchers find artificial sweeteners in nicotine pouches like Zyn & VELO. Discover the implications for health and regulation in their latest study.

Explore the potential risks of nicotine pouches like Zyn for oral health. Learn about popularity, ingredients, and the need for more research

Explore the vaping safety debate: Is vaping truly 95% safer than smoking? Discover insights and the myths with James Wigmore's series.

Canada nicotine pouch ban sparks debate. CAPHRA asks following NZ's success. Balanced regulations and innovation are key to reducing smoking.

New study by Tobacco Induced Diseases explores the awareness and use of nicotine pouches in Poland, shedding light on perceptions of harm.

The Daily Pouch analyzes a new study on nicotine pouch advertising, evaluating marketing and youth targeting claims across sports and digital ads.

NIH-funded study finds low nicotine pouch use among US adults. Disparities with other data suggest potential teen consumption.

Case study of a man who experienced nicotine poisoning after consuming too many nicotine pouches for study aid.

Discover key insights from the latest Eurobarometer survey on tobacco use in the EU. Learn about the myths surrounding tobacco marketing.

Explore the impact of nicotine pouches and vapes on smokers, focusing on low socioeconomic status. A new study reveals promising insights.

New research and historical snus data challenge claims that nicotine pouches lack safety evidence, shaping the harm reduction debate.

Is nicotine is as addictive as heroin? No - Uncover the origins of this claim, scrutinise the evidence, and challenge the common wisdom.

Explore the Truth Initiative's misleading interpretation of a study on nicotine pouches. See the real findings of these harm-reduction tools.

This editorial examines how biomarkers accelerate research on smoking alternatives like nicotine pouches and snus, advancing harm reduction science and policy.

Analyzing the relative harm of nicotine products, from combustible cigarettes to nicotine pouches and snus.

A new study reveals snus is Norway's most effective smoking cessation aid. Explore the research on usage trends, gender gaps, and nicotine pouch potential.

A new Ipsos poll shows Swedish ex-smokers rely on flavours and nicotine pouches to quit. Read how EU regulators can apply these harm reduction insights.

UK's Knowledge·Action·Change (K·A·C) launches a new Briefing Paper in its Global State of Tobacco Harm Reduction (GSTHR) project series.